ADA Issues Recs for Management of Diabetes in Primary Care

Share this content:
ADA Issues Recs for Management of Diabetes in Primary Care
ADA Issues Recs for Management of Diabetes in Primary Care

THURSDAY, March 3, 2016 (HealthDay News) -- New recommendations have been developed for diabetes, focusing on areas of importance for primary care providers. The clinical guideline was published online March 1 in the Annals of Internal Medicine.

James J. Chamberlain, M.D., from St. Mark's Hospital and St. Mark's Diabetes Center in Salt Lake City, and colleagues conducted a systematic review to revise or clarify recommendations for diabetes diagnosis and management for primary care providers, based on new evidence. The recommendations were rated and reviewed, and approved by the American Diabetes Association (ADA) Board of Directors. Feedback from the larger clinical community was incorporated.

The researchers summarized the ADA standards in eight areas of importance to primary care providers: diagnosis, glycemic targets, medical management, hypoglycemia, cardiovascular risk factor management, microvascular disease screening and management, and inpatient diabetes management. An individualized approach was recommended for each area, with self-monitoring emphasized as a key component of care.

"The synopsis focuses on eight key areas that are important to primary care providers," the authors write. "The recommendations highlight individualized care to manage the disease, prevent or delay complications, and improve outcomes."

Two authors disclosed financial ties to the pharmaceutical industry.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »